Growth Curves of Subependymal Giant Cell Tumors in Tuberous Sclerosis Complex

References

1. 1.↵
   2. Curatolo P,
   3. Moavero R,
   4. de Vries PJ

   . Neurological and neuropsychiatric aspects of tuberous sclerosis complex. Lancet Neurol 2015;14:733–45 doi:10.1016/S1474-4422(15)00069-1

   CrossRefPubMed
2. 2.↵
   2. Goh S,
   3. Butler W,
   4. Thiele EA

   . Subependymal giant cell tumors in tuberous sclerosis complex. Neurology 2004;63:1457–61 doi:10.1212/01.wnl.0000142039.14522.1a pmid:15505165

   Abstract/FREE Full Text
3. 3.↵
   2. Chan DL,
   3. Calder T,
   4. Lawson JA, et al

   . The natural history of subependymal giant cell astrocytomas in tuberous sclerosis complex: a review. Rev Neurosci 2018;29:295–301 doi:10.1515/revneuro-2017-0027 pmid:29211682

   CrossRefPubMed
4. 4.↵
   2. Adriaensen M,
   3. Schaefer-Prokop CM,
   4. Stijnen T, et al

   . Prevalence of subependymal giant cell tumors in patients with tuberous sclerosis and a review of the literature. Eur J Neurol 2009;16:691–96 doi:10.1111/j.1468-1331.2009.02567.x pmid:19236458

   CrossRefPubMed
5. 5.↵
   2. Kumari K,
   3. Sharma MC,
   4. Kakkar A, et al

   . Role of mTOR signaling pathway in the pathogenesis of subependymal giant cell astrocytoma: a study of 28 cases. Neurol India 2016;64:988–94 doi:10.4103/0028-3886.190274 pmid:27625244

   CrossRefPubMed
6. 6.↵
   2. Roth J,
   3. Roach ES,
   4. Bartels U, et al

   . Subependymal giant cell astrocytoma: diagnosis, screening, and treatment: recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012. Pediatr Neurol 2013;49:439–44 doi:10.1016/j.pediatrneurol.2013.08.017 pmid:24138953

   CrossRefPubMed
7. 7.↵
   2. Nabbout R,
   3. Santos M,
   4. Rolland Y, et al

   . Early diagnosis of subependymal giant cell astrocytoma in children with tuberous sclerosis. J Neurol Neurosurg Psychiatry 1999;66:370–75 doi:10.1136/jnnp.66.3.370 pmid:10084537

   Abstract/FREE Full Text
8. 8.↵
   2. Roach ES,
   3. Sparagana SP

   . Diagnosis of tuberous sclerosis complex. J Child Neurol 2004;19:643–49 doi:10.1177/08830738040190090301 pmid:15563009

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Jóźwiak S,
   3. Nabbout R,
   4. Curatolo P

   , participants of the TSC Consensus Meeting for SEGA and Epilepsy Management. Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): clinical recommendations. Eur J Paediatr Neurol 2013;17:348–52 doi:10.1016/j.ejpn.2012.12.008 pmid:23391693

   CrossRefPubMed
10. 10.↵
    2. de Ribaupierre S,
    3. Dorfmüller G,
    4. Bulteau C, et al

    . Subependymal giant-cell astrocytomas in pediatric tuberous sclerosis disease: when should we operate? Neurosurgery 2007;60:83–90 doi:10.1227/01.NEU.0000249216.19591.5D pmid:17228255

    CrossRefPubMed
11. 11.↵
    2. Fohlen M,
    3. Ferrand-Sorbets S,
    4. Delalande O, et al

    . Surgery for subependymal giant cell astrocytomas in children with tuberous sclerosis complex. Childs Nerv Syst 2018;34:1511–19 doi:10.1007/s00381-018-3826-6 pmid:29766265

    CrossRefPubMed
12. 12.↵
    2. Stawiski K,
    3. Trelińska J,
    4. Baranska D, et al

    . What are the true volumes of SEGA tumors? Reliability of planimetric and popular semi-automated image segmentation methods. MAGMA 2017;30:397–405 doi:10.1007/s10334-017-0614-3 pmid:28321524

    CrossRefPubMed